Growth Metrics

Merck (MRK) Revenue (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -0.70%
Dec 31, 2025 -5.07%
Sep 30, 2025 9.30%
Jun 30, 2025 1.78%
Mar 31, 2025 -0.61%
Dec 31, 2024 -6.20%
Sep 30, 2024 3.38%
Jun 30, 2024 2.14%
Mar 31, 2024 7.83%
Dec 31, 2023 -8.34%
Sep 30, 2023 6.17%
Jun 30, 2023 3.78%
Mar 31, 2023 4.75%
Dec 31, 2022 -7.55%
Sep 30, 2022 2.51%
Jun 30, 2022 -8.23%
Mar 31, 2022 17.60%
Dec 31, 2021 2.79%
Sep 30, 2021 15.37%
Jun 30, 2021 7.29%
Mar 31, 2021 -2.93%
Dec 31, 2020 0.17%
Sep 30, 2020 16.85%
Jun 30, 2020 -22.43%
Mar 31, 2020 190.60%
Dec 31, 2019 -66.53%
Sep 30, 2019 5.42%
Jun 30, 2019 8.73%
Mar 31, 2019 -1.65%
Dec 31, 2018 1.89%
Sep 30, 2018 3.14%
Jun 30, 2018 4.26%
Mar 31, 2018 -3.80%
Dec 31, 2017 1.05%
Sep 30, 2017 3.98%
Jun 30, 2017 5.26%
Mar 31, 2017 -6.73%
Dec 31, 2016 -4.00%
Sep 30, 2016 7.03%
Jun 30, 2016 5.71%
Mar 31, 2016 -8.84%
Dec 31, 2015 1.41%
Sep 30, 2015 2.94%
Jun 30, 2015 3.82%
Mar 31, 2015 -10.08%
Dec 31, 2014 -0.71%
Sep 30, 2014 -3.45%
Jun 30, 2014 6.53%
Mar 31, 2014 -9.33%
Dec 31, 2013 2.61%
Sep 30, 2013 0.20%
Jun 30, 2013 3.18%
Mar 31, 2013 -9.08%
Dec 31, 2012 2.17%
Sep 30, 2012 -6.69%
Jun 30, 2012 4.94%
Mar 31, 2012 -4.58%
Dec 31, 2011 2.26%
Sep 30, 2011 -1.06%
Jun 30, 2011 4.93%
Mar 31, 2011 -4.25%
Dec 31, 2010 8.71%
Sep 30, 2010 -1.95%
Jun 30, 2010 -0.67%
Mar 31, 2010 13.17%
Dec 31, 2009 66.84%
Sep 30, 2009 2.54%
Jun 30, 2009 9.56%